Article 3 - CONTROL MEASURES FOR COMMUNICABLE DISEASES AND INFESTATIONS
- § R9-6-301 - Definitions
- § R9-6-302 - Local Health Agency Control Measures
- § R9-6-303 - Isolation, Quarantine, Exclusion, and Other Control Measures
- § R9-6-304 - Food Establishment Control Measures
- § R9-6-305 - Control Measures for Multi-drug-resistant Organisms
- § R9-6-306 - Amebiasis
- § R9-6-307 - Anaplasmosis
- § R9-6-308 - Anthrax
- § R9-6-309 - Arboviral Infection
- § R9-6-310 - Babesiosis
- § R9-6-311 - Basidiobolomycosis
- § R9-6-312 - Blastomycosis Infection
- § R9-6-313 - Botulism
- § R9-6-314 - Brucellosis
- § R9-6-315 - Campylobacteriosis
- § R9-6-316 - Candida auris
- § R9-6-317 - Carbapenem-resistant Acinetobacter baumannii
- § R9-6-318 - Carbapenem-resistant Enterobacterales
- § R9-6-319 - Carbapenem-resistant Pseudomonas aeruginosa
- § R9-6-320 - Chagas Infection and Related Disease (American Trypanosomiasis)
- § R9-6-321 - Chancroid (Haemophilus ducreyi)
- § R9-6-322 - Chikungunya
- § R9-6-323 - Chlamydia trachomatis Infection
- § R9-6-324 - Cholera
- § R9-6-325 - Clostridioides difficile
- § R9-6-326 - Coccidioidomycosis (Valley Fever)
- § R9-6-327 - Colorado Tick Fever
- § R9-6-328 - Conjunctivitis: Acute
- § R9-6-329 - Creutzfeldt-Jakob Disease
- § R9-6-330 - Cronobacter Infection in an Infant
- § R9-6-331 - Cryptosporidiosis
- § R9-6-332 - Cyclospora Infection
- § R9-6-333 - Cysticercosis
- § R9-6-334 - Dengue
- § R9-6-335 - Diarrhea, Nausea, or Vomiting
- § R9-6-336 - Diphtheria
- § R9-6-337 - Ehrlichiosis
- § R9-6-338 - Emerging or Exotic Disease
- § R9-6-339 - Encephalitis, Viral or Parasitic
- § R9-6-340 - Escherichia coli, Shiga Toxin-producing
- § R9-6-341 - Giardiasis
- § R9-6-342 - Glanders
- § R9-6-343 - Gonorrhea
- § R9-6-344 - Haemophilus influenzae: Invasive Disease
- § R9-6-345 - Hansen's Disease (Leprosy)
- § R9-6-346 - Hantavirus Infection
- § R9-6-347 - Hemolytic Uremic Syndrome
- § R9-6-348 - Hepatitis A
- § R9-6-349 - Hepatitis B and Hepatitis D
- § R9-6-350 - Hepatitis C
- § R9-6-351 - Hepatitis E
- § R9-6-352 - HIV Infection and Related Disease
- § R9-6-353 - Influenza-Associated Mortality in a Child
- § R9-6-354 - Legionellosis (Legionnaires' Disease)
- § R9-6-355 - Leptospirosis
- § R9-6-356 - Listeriosis
- § R9-6-357 - Lyme Disease
- § R9-6-358 - Lymphocytic Choriomeningitis
- § R9-6-359 - Malaria
- § R9-6-360 - Measles (Rubeola)
- § R9-6-361 - Melioidosis
- § R9-6-362 - Meningococcal Invasive Disease
- § R9-6-363 - Methicillin-resistant Staphylococcus aureus (MRSA)
- § R9-6-364 - Middle East Respiratory Syndrome (MERS)
- § R9-6-365 - Mpox
- § R9-6-366 - Mumps
- § R9-6-367 - Mycoplasma genitalium Infection
- § R9-6-368 - Norovirus
- § R9-6-369 - Novel Coronavirus
- § R9-6-370 - Novel Influenza Virus
- § R9-6-371 - Pediculosis (Lice Infestation)
- § R9-6-372 - Pertussis (Whooping Cough)
- § R9-6-373 - Plague
- § R9-6-374 - Poliomyelitis (Paralytic or Non-paralytic)
- § R9-6-375 - Psittacosis (Ornithosis)
- § R9-6-376 - Q Fever
- § R9-6-377 - Rabies in a Human
- § R9-6-378 - Relapsing Fever (Borreliosis)
- § R9-6-379 - Respiratory Disease in a Health Care Institution or Correctional Facility
- § R9-6-380 - Rubella (German Measles)
- § R9-6-381 - Rubella Syndrome, Congenital
- § R9-6-382 - Salmonellosis
- § R9-6-383 - Severe Acute Respiratory Syndrome (SARS)
- § R9-6-384 - Scabies
- § R9-6-385 - Shigellosis
- § R9-6-386 - Smallpox
- § R9-6-387 - Spotted Fever Rickettsiosis (e.g., Rocky Mountain Spotted Fever)
- § R9-6-388 - Streptococcal Group A Infection
- § R9-6-389 - Streptococcal Group B Invasive Infection in an Infant Younger Than 90 Days of Age
- § R9-6-390 - Streptococcus pneumoniae Invasive Infection
- § R9-6-391 - Syphilis
- § R9-6-392 - Taeniasis
- § R9-6-393 - Tetanus
- § R9-6-394 - Toxic Shock Syndrome
- § R9-6-395 - Trichinosis
- § R9-6-396 - Tuberculosis
- § R9-6-397 - Tularemia
- § R9-6-398 - Typhoid Fever
- § R9-6-399 - Typhus Fever
- § R9-6-3100 - Vaccinia-related Adverse Event
- § R9-6-3101 - Vancomycin-Resistant or Vancomycin-Intermediate Staphylococcus aureus
- § R9-6-3102 - Varicella (Chickenpox)
- § R9-6-3103 - Vibrio Infection
- § R9-6-3104 - Viral Hemorrhagic Fever
- § R9-6-3105 - West Nile Virus Infection
- § R9-6-3106 - Yellow Fever
- § R9-6-3107 - Yersiniosis (Enteropathogenic Yersinia)
- § R9-6-3108 - Zika Virus Infection
- Exhibit III-A - [REPEALED]
- Exhibit III-B - [REPEALED]
- Exhibit III-C - [REPEALED]
- Exhibit III-D - [REPEALED]
- Exhibit III-E - [REPEALED]
- Exhibit III-F - [REPEALED]
- Exhibit III-G - [REPEALED]
- Exhibit III-H - [REPEALED]
- Exhibit III-I - [REPEALED]
- Exhibit III-J - [REPEALED]
- Exhibit III-K - [REPEALED]
- Exhibit III-L - [REPEALED]
- Exhibit III-M - [REPEALED]
- Exhibit III-N - [REPEALED]
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
- § R9-6-301 - Definitions
- § R9-6-302 - Local Health Agency Control Measures
- § R9-6-303 - Isolation, Quarantine, Exclusion, and Other Control Measures
- § R9-6-304 - Food Establishment Control Measures
- § R9-6-305 - Control Measures for Multi-drug-resistant Organisms
- § R9-6-306 - Amebiasis
- § R9-6-307 - Anaplasmosis
- § R9-6-308 - Anthrax
- § R9-6-309 - Arboviral Infection
- § R9-6-310 - Babesiosis
- § R9-6-311 - Basidiobolomycosis
- § R9-6-312 - Botulism
- § R9-6-313 - Brucellosis
- § R9-6-314 - Campylobacteriosis
- § R9-6-315 - Carbapenem-resistant Enterobacteriaceae
- § R9-6-316 - Chagas Infection and Related Disease (American Trypanosomiasis)
- § R9-6-317 - Chancroid (Haemophilus ducreyi)
- § R9-6-318 - Chikungunya
- § R9-6-319 - Chlamydia trachomatis Infection
- § R9-6-320 - Cholera
- § R9-6-321 - Clostridium difficile
- § R9-6-322 - Coccidioidomycosis (Valley Fever)
- § R9-6-323 - Colorado Tick Fever
- § R9-6-324 - Conjunctivitis: Acute
- § R9-6-325 - Creutzfeldt-Jakob Disease
- § R9-6-326 - Cryptosporidiosis
- § R9-6-327 - Cyclospora Infection
- § R9-6-328 - Cysticercosis
- § R9-6-329 - Dengue
- § R9-6-330 - Diarrhea, Nausea, or Vomiting
- § R9-6-331 - Diphtheria
- § R9-6-332 - Ehrlichiosis
- § R9-6-333 - Emerging or Exotic Disease
- § R9-6-334 - Encephalitis, Viral or Parasitic
- § R9-6-335 - Escherichia coli, Shiga Toxin-producing
- § R9-6-336 - Giardiasis
- § R9-6-337 - Glanders
- § R9-6-338 - Gonorrhea
- § R9-6-339 - Haemophilus influenzae: Invasive Disease
- § R9-6-340 - Hansen's Disease (Leprosy)
- § R9-6-341 - Hantavirus Infection
- § R9-6-342 - Hemolytic Uremic Syndrome
- § R9-6-343 - Hepatitis A
- § R9-6-344 - Hepatitis B and Hepatitis D
- § R9-6-345 - Hepatitis C
- § R9-6-346 - Hepatitis E
- § R9-6-347 - HIV Infection and Related Disease
- § R9-6-348 - Influenza-Associated Mortality in a Child
- § R9-6-349 - Legionellosis (Legionnaires' Disease)
- § R9-6-350 - Leptospirosis
- § R9-6-351 - Listeriosis
- § R9-6-352 - Lyme Disease
- § R9-6-353 - Lymphocytic Choriomeningitis
- § R9-6-354 - Malaria
- § R9-6-355 - Measles (Rubeola)
- § R9-6-356 - Melioidosis
- § R9-6-357 - Meningococcal Invasive Disease
- § R9-6-358 - Methicillin-resistant Staphylococcus aureus (MRSA)
- § R9-6-359 - Mumps
- § R9-6-360 - Norovirus
- § R9-6-361 - Novel Coronavirus (e.g., SARS or MERS)
- § R9-6-362 - Pediculosis (Lice Infestation)
- § R9-6-363 - Pertussis (Whooping Cough)
- § R9-6-364 - Plague
- § R9-6-365 - Poliomyelitis (Paralytic or Non-paralytic)
- § R9-6-366 - Psittacosis (Ornithosis)
- § R9-6-367 - Q Fever
- § R9-6-368 - Rabies in a Human
- § R9-6-369 - Relapsing Fever (Borreliosis)
- § R9-6-370 - Respiratory Disease in a Health Care Institution or Correctional Facility
- § R9-6-371 - Rubella (German Measles)
- § R9-6-372 - Rubella Syndrome, Congenital
- § R9-6-373 - Salmonellosis
- § R9-6-374 - Scabies
- § R9-6-375 - Shigellosis
- § R9-6-376 - Smallpox
- § R9-6-377 - Spotted Fever Rickettsiosis (e.g., Rocky Mountain Spotted Fever)
- § R9-6-378 - Streptococcal Group A Infection
- § R9-6-379 - Streptococcal Group B Invasive Infection in an Infant Younger Than 90 Days of Age
- § R9-6-380 - Streptococcus pneumoniae Invasive Infection
- § R9-6-381 - Syphilis
- § R9-6-382 - Taeniasis
- § R9-6-383 - Tetanus
- § R9-6-384 - Toxic Shock Syndrome
- § R9-6-385 - Trichinosis
- § R9-6-386 - Tuberculosis
- § R9-6-387 - Tularemia
- § R9-6-388 - Typhoid Fever
- § R9-6-389 - Typhus Fever
- § R9-6-390 - Vaccinia-related Adverse Event
- § R9-6-391 - Vancomycin-Resistant or Vancomycin-Intermediate Staphylococcus aureus
- § R9-6-392 - Varicella (Chickenpox)
- § R9-6-393 - Vibrio Infection
- § R9-6-394 - Viral Hemorrhagic Fever
- § R9-6-395 - West Nile Virus Infection
- § R9-6-396 - Yellow Fever
- § R9-6-397 - Yersiniosis (Enteropathogenic Yersinia)
- § R9-6-398 - Zika Virus Infection
- Exhibit III-A - [REPEALED]
- Exhibit III-B - [REPEALED]
- Exhibit III-C - [REPEALED]
- Exhibit III-D - [REPEALED]
- Exhibit III-E - [REPEALED]
- Exhibit III-F - [REPEALED]
- Exhibit III-G - [REPEALED]
- Exhibit III-H - [REPEALED]
- Exhibit III-I - [REPEALED]
- Exhibit III-J - [REPEALED]
- Exhibit III-K - [REPEALED]
- Exhibit III-L - [REPEALED]
- Exhibit III-M - [REPEALED]
- Exhibit III-N - [REPEALED]